SPECTRIX THERAPEUTICS LLC has a total of 18 patent applications. It decreased the IP activity by 54.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, measurement and organic fine chemistry are XI AN CHIHO PHARMACEUTICAL CO LTD, LUNAN HOPE PHARMACEUTICAL CO LTD and HANGZHOU HUQINGYUTANG CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 2 | |
#4 | Republic of Korea | 2 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Israel | 1 | |
#10 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Tengler Mark | 15 |
#2 | Mark Tengler | 2 |
Publication | Filing date | Title |
---|---|---|
WO2019094292A1 | Compositions and methods of providing thyroid hormone or analogs thereof | |
US2019060462A1 | Compound to treat Sjogren's syndrome | |
US2018064669A1 | Compositions and methods of providing thyroid hormone or analogs thereof | |
KR20180132955A | Compositions and methods for providing thyroid hormones or analogs thereof | |
CN109475605A | Thyroid hormone or the composition and method of its analog are provided |